{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:19Z","timestamp":1786505239358,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ50692"],"award-info":[{"award-number":["2025JJ50692"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156625","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:30:15Z","timestamp":1784244615000},"page":"156625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RBCK1 promotes chemotherapy resistance in bladder carcinoma by targeting HLTF"],"prefix":"10.1016","volume":"286","author":[{"given":"Xin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Pengwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bin Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prp.2026.156625_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.07.013","article-title":"SnapShot: Bladder Cancer","volume":"34","author":"Hurst","year":"2018","journal-title":"Cancer Cell."},{"issue":"12","key":"10.1016\/j.prp.2026.156625_bib2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/ng.3692","article-title":"Clonal evolution of chemotherapy-resistant urothelial carcinoma","volume":"48","author":"Faltas","year":"2016","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/annonc\/mds583","article-title":"Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine\/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16\/03)","volume":"24","author":"Bamias","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2026.156625_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2015.64.1076","article-title":"Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer","volume":"34","author":"Galsky","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2026.156625_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091594","article-title":"Immune Checkpoint Inhibitors and Antibody-Drug Conjugates in Urothelial Carcinoma: Current Landscape and Future Directions","volume":"17","author":"Yajima","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.prp.2026.156625_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prp.2026.156625_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2026.111304","article-title":"Single-cell insights into cisplatin resistance mechanisms in bladder cancer tumor microenvironment","volume":"302","author":"Xu","year":"2026","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41420-025-02424-w","article-title":"VANGL2 downregulates HINT1 to inhibit the ATM-p53 pathway and promote cisplatin resistance in small cell lung cancer","volume":"11","author":"Xie","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"12","key":"10.1016\/j.prp.2026.156625_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41419-024-07265-6","article-title":"TIP60 enhances cisplatin resistance via regulating \u0394Np63\u03b1 acetylation in SCC","volume":"15","author":"Hira","year":"2024","journal-title":"Cell. Death Dis."},{"issue":"10","key":"10.1016\/j.prp.2026.156625_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13659","article-title":"ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner","volume":"57","author":"Liu","year":"2024","journal-title":"Cell. Prolif."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s42003-023-05721-1","article-title":"SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation","volume":"7","author":"Gong","year":"2024","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.prp.2026.156625_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41416-022-02058-0","article-title":"Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer","volume":"128","author":"Ren","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10.1016\/j.prp.2026.156625_bib13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/0118715206304668240729093158","article-title":"Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2\/STAT3 Pathway","volume":"24","author":"Li","year":"2024","journal-title":"Anticancer. Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1134\/S0006297917040095","article-title":"MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K\/AKT and JAK\/STAT Pathways by Upregulation of NRAS in Bladder Cancer","volume":"82","author":"Li","year":"2017","journal-title":"Biochemistry (Mosc"},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41419-025-07593-1","article-title":"PLA2G7 promotes immune evasion of bladder cancer through the JAK-STAT-PDL1 axis","volume":"16","author":"Peng","year":"2025","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1186\/s12967-025-07613-w","article-title":"ERO1A promotes the proliferation, migration and invasion of bladder cancer through ALOX5 mediated activation of JAK-STAT signaling pathway","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","article-title":"E3 ubiquitin ligases: styles, structures and functions","volume":"2","author":"Yang","year":"2021","journal-title":"Mol. Biomed."},{"issue":"Pt 2","key":"10.1016\/j.prp.2026.156625_bib18","article-title":"PCDH7 promotes EMT and chemoresistance by stabilizing ZEB1 via inhibition of TRIM26-mediated ubiquitination in lung adenocarcinoma","volume":"243","author":"Chen","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2026.156625_bib19","article-title":"Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade","author":"Yang","year":"2026","journal-title":"Cell. Death Differ."},{"issue":"8","key":"10.1016\/j.prp.2026.156625_bib20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.tig.2018.04.006","article-title":"Rad5, HLTF, and SHPRH: A Fresh View of an Old Story","volume":"34","author":"Elserafy","year":"2018","journal-title":"Trends Genet."},{"issue":"34","key":"10.1016\/j.prp.2026.156625_bib21","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.1073\/pnas.0805685105","article-title":"Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks","volume":"105","author":"Motegi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.prp.2026.156625_bib22","first-page":"11340","article-title":"Regulation of HLTF-mediated PCNA polyubiquitination by RFC and PCNA monoubiquitination levels determines choice of damage tolerance pathway","volume":"46","author":"Masuda","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.prp.2026.156625_bib23","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.0800563105","article-title":"Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination","volume":"105","author":"Unk","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00018-007-7392-4","article-title":"The helicase-like transcription factor and its implication in cancer progression","volume":"65","author":"Debauve","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"17","key":"10.1016\/j.prp.2026.156625_bib25","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1093\/nar\/gkz631","article-title":"Rad5 dysregulation drives hyperactive recombination at replication forks resulting in cisplatin sensitivity and genome instability","volume":"47","author":"Bryant","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156625_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030463","article-title":"The Human RAD5 Homologs, HLTF and SHPRH, Have Separate Functions in DNA Damage Tolerance Dependent on The DNA Lesion Type","volume":"10","author":"Seelinger","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41389-023-00447-5","article-title":"HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK\/MAPK pathway","volume":"12","author":"Xu","year":"2023","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.prp.2026.156625_bib28","first-page":"108","article-title":"HLTF\/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from Cervical Precancerous Lesions to Cervical Carcinoma in vitro","volume":"90","author":"Wang","year":"2024","journal-title":"Gynecol. Obstet. Invest."},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00432-010-0925-5","article-title":"Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity","volume":"137","author":"Cho","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156625_bib30","first-page":"2780","article-title":"HLTF suppresses the migration and invasion of colorectal cancer cells via TGF\u2011\u03b2\/SMAD signaling in vitro","volume":"53","author":"Liu","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156625_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10409238.2017.1380597","article-title":"Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability","volume":"52","author":"Poole","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00018-015-2060-6","article-title":"The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?","volume":"73","author":"Dhont","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"15","key":"10.1016\/j.prp.2026.156625_bib33","first-page":"7331","article-title":"HOXA1 binds RBCK1\/HOIL-1 and TRAF2 and modulates the TNF\/NF-\u03baB pathway in a transcription-independent manner","volume":"44","author":"Taminiau","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41420-022-01126-x","article-title":"RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31","volume":"8","author":"Chen","year":"2022","journal-title":"Cell. Death Discov."},{"issue":"13","key":"10.1016\/j.prp.2026.156625_bib35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41388-023-02613-w","article-title":"The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.prp.2026.156625_bib36","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1073\/pnas.1905873116","article-title":"The E3 ligase HOIL-1 catalyses ester bond formation between ubiquitin and components of the Myddosome in mammalian cells","volume":"116","author":"Kelsall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11 Pt A","key":"10.1016\/j.prp.2026.156625_bib37","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.bbagen.2016.07.021","article-title":"JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells","volume":"1860","author":"Ojha","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.prp.2026.156625_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031106","article-title":"STAT3\/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy","volume":"21","author":"Hindupur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156625_bib39","article-title":"RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC)","volume":"118","author":"Liu","year":"2019","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"10.1016\/j.prp.2026.156625_bib40","article-title":"Regulation of ER\u03b1 Stability and Estrogen Signaling in Breast Cancer by HOIL-1","volume":"11","author":"Ding","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156625_bib41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s13577-022-00681-w","article-title":"Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1","volume":"35","author":"Wang","year":"2022","journal-title":"Hum. Cell."},{"issue":"2","key":"10.1016\/j.prp.2026.156625_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s43018-019-0021-y","article-title":"MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination","volume":"1","author":"Cong","year":"2020","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-019-1488-2","article-title":"RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma","volume":"10","author":"Yu","year":"2019","journal-title":"Cell. Death Dis."},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112296","article-title":"Arginine shortage induces replication stress and confers genotoxic resistance by inhibiting histone H4 translation and promoting PCNA ubiquitination","volume":"42","author":"Wang","year":"2023","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-68752-2","article-title":"Structural basis for fork reversal and RAD51 regulation by the SCF ubiquitin ligase complex of F-box helicase 1","volume":"17","author":"Greer","year":"2026","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.prp.2026.156625_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad012","article-title":"Degradation of helicase-like transcription factor (HLTF) by \u03b2-TrCP promotes hepatocarcinogenesis via activation of the p62\/mTOR axis","volume":"15","author":"Tan","year":"2023","journal-title":"J. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41698-025-00947-0","article-title":"Lestaurtinib's antineoplastic activity converges on JAK\/STAT signaling to inhibit treatment na\u00efve and therapy resistant forms ovarian cancer","volume":"9","author":"Rodman","year":"2025","journal-title":"NPJ Precis. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2026.156625_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells13171463","article-title":"Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models","volume":"13","author":"Singh","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","article-title":"Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"30","key":"10.1016\/j.prp.2026.156625_bib50","article-title":"DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR-JAK2-STAT3 Pathway","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.prp.2026.156625_bib51","article-title":"A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy","volume":"8","author":"Zhang","year":"2025","journal-title":"Res. (Wash. D. C. )"},{"issue":"1","key":"10.1016\/j.prp.2026.156625_bib52","article-title":"Miniature and versatile genome regulation TnpB-\u03c9RNA toolkits facilitate cancer immunotherapy","volume":"17","author":"Lu","year":"2026","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.prp.2026.156625_bib53","article-title":"Targeting TPX2-dependent lineage plasticity by CDK4\/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma","volume":"7","author":"Chen","year":"2026","journal-title":"Cell. Rep. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:36:42Z","timestamp":1786502202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0344033826002785"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156625","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RBCK1 promotes chemotherapy resistance in bladder carcinoma by targeting HLTF","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156625"}}